合成手性γ-氨基丁酸（GABA）受体亚型选择性配体，作为治疗精神分裂症和抑郁症的潜在药物。
Synthesis of chiral GABA receptor subtype selective ligands as potential agents to treat schizophrenia as well as depression.
作者信息
Li Guanguan, Stephen Michael R, Kodali Revathi, Zahn Nicolas M, Poe Michael M, Tiruveedhula V V N Phani Babu, Huber Alec T, Schussman Melissa K, Qualmann Krista, Panhans Cristina M, Raddatz Nicholas J, Baker David A, Prevot Thomas D, Banasr Mounira, Sibille Etienne, Arnold Leggy A, Cook James M
机构信息
Department of Chemistry and Biochemistry, Milwaukee Institute for Drug Discovery, University of Wisconsin-Milwaukee, Milwaukee, Wisconsin 53201, United States.
Department of Biomedical Science, Marquette University, Milwaukee, Wisconsin 53233, United States.
出版信息
ARKIVOC. 2018;2018(4):158-182. doi: 10.24820/ark.5550190.p010.460. Epub 2018 Mar 11.
Abstract
A series of novel imidazobenzodiazepine analogs of the lead chiral ligand SH-053-2'F--CH (), an α2/α3/α5 (Bz)GABA (A)ergic receptor subtype selective ligand, which reversed PCP-induced prepulse inhibition (PPI) of acoustic startle, were synthesized. These chiral ()-CH ligands are targeted for the treatment of schizophrenia and depression. These new ligands were designed by modifying the liable ester functionality in to improve the metabolic stability, cytotoxicity, and activity as compared to . Based on the data to date, the most promising ligands are the -cyclopropyl amide GL-I-55 () and the methyl bioisostere GL-I-65 (). The metabolic stability, cytotoxicity and locomotor effects are described in this report. Based on these results, and are the most promising for further pharmacology.
摘要
合成了一系列新型咪唑并苯二氮䓬类似物，其为先导手性配体SH-053-2'F--CH（一种α2/α3/α5（Bz）GABA（A）能受体亚型选择性配体，可逆转苯环己哌啶诱导的听觉惊吓前脉冲抑制（PPI））的类似物。这些手性（）-CH配体旨在用于治疗精神分裂症和抑郁症。通过修饰中的不稳定酯官能团来设计这些新配体，以与相比提高代谢稳定性、细胞毒性和活性。根据迄今为止的数据，最有前景的配体是环丙基酰胺GL-I-55（）和甲基生物电子等排体GL-I-65（）。本报告描述了它们的代谢稳定性、细胞毒性和运动效应。基于这些结果，和在进一步的药理学研究中最具前景。
相似文献
1
Synthesis of chiral GABA receptor subtype selective ligands as potential agents to treat schizophrenia as well as depression.合成手性γ-氨基丁酸（GABA）受体亚型选择性配体，作为治疗精神分裂症和抑郁症的潜在药物。
ARKIVOC. 2018;2018(4):158-182. doi: 10.24820/ark.5550190.p010.460. Epub 2018 Mar 11.
2
Distinct sex-dependent behavioral responses induced by two positive allosteric modulators of alpha 5 subunit-containing GABA receptors.两种含 alpha 5 亚单位 GABA 受体正变构调节剂诱导的性别依赖性行为反应。
Behav Brain Res. 2022 Jun 25;428:113832. doi: 10.1016/j.bbr.2022.113832. Epub 2022 Mar 5.
3
Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats?新型 GABA A 受体正变构调节剂：在α1 加α5 与α2 加α3 亚基上的活性的细微差异是否解释了它们在大鼠行为效应上的差异？
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17;34(2):376-86. doi: 10.1016/j.pnpbp.2010.01.004. Epub 2010 Jan 13.
4
A Benzodiazepine Ligand with Improved GABA Receptor 5-Subunit Selectivity Driven by Interactions with Loop C.一种苯二氮䓬类配体，通过与环 C 的相互作用，提高了 GABA 受体 5 亚基选择性。
Mol Pharmacol. 2021 Jan;99(1):39-48. doi: 10.1124/molpharm.120.000067. Epub 2020 Dec 2.
5
A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model.α5γ-氨基丁酸A（GABA(A)）苯二氮䓬受体模型更新药效团综述。
Int J Med Chem. 2015;2015:430248. doi: 10.1155/2015/430248. Epub 2015 Nov 10.
6
Enhancing the function of alpha5-subunit-containing GABAA receptors promotes action potential firing of neocortical neurons during up-states.增强含有 alpha5 亚基的 GABA A 受体的功能可促进上电状态下新皮层神经元的动作电位发放。
Eur J Pharmacol. 2013 Mar 5;703(1-3):18-24. doi: 10.1016/j.ejphar.2013.01.034. Epub 2013 Feb 1.
7
Selective targeting of the α5-subunit of GABAA receptors relaxes airway smooth muscle and inhibits cellular calcium handling.选择性靶向γ-氨基丁酸A（GABAA）受体的α5亚基可舒张气道平滑肌并抑制细胞内钙处理。
Am J Physiol Lung Cell Mol Physiol. 2015 May 1;308(9):L931-42. doi: 10.1152/ajplung.00107.2014. Epub 2015 Feb 6.
8
Are GABAA receptors containing alpha5 subunits contributing to the sedative properties of benzodiazepine site agonists?含有α5亚基的GABAA受体是否有助于苯二氮䓬类位点激动剂的镇静特性？
Neuropsychopharmacology. 2008 Jan;33(2):332-9. doi: 10.1038/sj.npp.1301403. Epub 2007 Mar 28.
9
Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2'F-S-CH₃ in an immune-mediated neurodevelopmental disruption model.苯二氮䓬类正变构调节剂SH-053-2'F-S-CH₃在免疫介导的神经发育破坏模型中的行为效应
Int J Neuropsychopharmacol. 2015 Jan 30;18(4):pyu055. doi: 10.1093/ijnp/pyu055.
10
PWZ-029, a compound with moderate inverse agonist functional selectivity at GABA(A) receptors containing alpha5 subunits, improves passive, but not active, avoidance learning in rats.PWZ - 029是一种对含有α5亚基的γ-氨基丁酸A（GABA(A)）受体具有适度反向激动剂功能选择性的化合物，它能改善大鼠的被动回避学习，但不能改善主动回避学习。
Brain Res. 2008 May 7;1208:150-9. doi: 10.1016/j.brainres.2008.02.020. Epub 2008 Feb 19.
引用本文的文献
1
Design, Synthesis, and Biological Evaluation of Novel Spiro Imidazobenzodiazepines to Identify Improved Inhaled Bronchodilators.新型螺环咪唑并苯并二氮䓬类化合物的设计、合成与生物评价，以寻找改良的吸入式支气管扩张剂。
J Med Chem. 2023 Jul 27;66(14):9853-9865. doi: 10.1021/acs.jmedchem.3c00647. Epub 2023 Jul 7.
2
Symptomatic and neurotrophic effects of GABAA receptor positive allosteric modulation in a mouse model of chronic stress.慢性应激小鼠模型中 GABAA 受体正变构调节的症状和神经营养作用。
Neuropsychopharmacology. 2022 Aug;47(9):1608-1619. doi: 10.1038/s41386-022-01360-y. Epub 2022 Jun 14.
3
Comparative pharmacodynamic and pharmacokinetic study of MIDD0301 and its (S) enantiomer.MIDD0301 及其（S）对映异构体的比较药效学和药代动力学研究。
Drug Dev Res. 2022 Jun;83(4):979-992. doi: 10.1002/ddr.21926. Epub 2022 Mar 4.
4
Development of Inhaled GABA Receptor Modulators to Improve Airway Function in Bronchoconstrictive Disorders.开发吸入性γ-氨基丁酸受体调节剂以改善支气管收缩性疾病的气道功能。
ACS Pharmacol Transl Sci. 2022 Feb 1;5(2):80-88. doi: 10.1021/acsptsci.1c00238. eCollection 2022 Feb 11.
5
Design, synthesis and characterization of novel gamma‑aminobutyric acid type A receptor ligands.新型γ-氨基丁酸A型受体配体的设计、合成与表征
ARKIVOC. 2020;2020(Pt 7):242-256. doi: 10.24820/ark.5550190.p011.398. Epub 2020 Dec 2.
6
Reversal of Age-Related Neuronal Atrophy by α5-GABAA Receptor Positive Allosteric Modulation.通过α5-GABAA 受体正变构调节逆转与年龄相关的神经元萎缩。
Cereb Cortex. 2021 Jan 5;31(2):1395-1408. doi: 10.1093/cercor/bhaa310.
7
A Structure-Activity Relationship Comparison of Imidazodiazepines Binding at Kappa, Mu, and Delta Opioid Receptors and the GABA Receptor.阿片受体和 GABA 受体上的咪唑并二氮䓬类化合物结合的构效关系比较。
Molecules. 2020 Aug 25;25(17):3864. doi: 10.3390/molecules25173864.
8
Improved Synthesis of Anxiolytic, Anticonvulsant and Antinociceptive α2/α3-GABA(A)ergic Receptor Subtype Selective Ligands as Promising Agents to Treat Anxiety, Epilepsy, as well as Neuropathic Pain.抗焦虑、抗惊厥和抗伤害感受的α2/α3 - GABA(A)能受体亚型选择性配体的改进合成：有望用于治疗焦虑症、癫痫以及神经性疼痛的药物
Synthesis (Stuttg). 2018 Oct;50(20):4124-4132. doi: 10.1055/s-0037-1610211.
9
Novel Benzodiazepine-Like Ligands with Various Anxiolytic, Antidepressant, or Pro-Cognitive Profiles.具有多种抗焦虑、抗抑郁或促认知特性的新型苯二氮䓬类配体。
Mol Neuropsychiatry. 2019 Apr;5(2):84-97. doi: 10.1159/000496086. Epub 2019 Jan 23.
本文引用的文献
1
Somatostatin-Positive Gamma-Aminobutyric Acid Interneuron Deficits in Depression: Cortical Microcircuit and Therapeutic Perspectives.抑郁障碍中生长抑素阳性γ-氨基丁酸中间神经元缺失：皮质微回路与治疗展望
Biol Psychiatry. 2017 Oct 15;82(8):549-559. doi: 10.1016/j.biopsych.2017.05.024. Epub 2017 Jun 8.
2
Positive modulation of α5 GABA receptors in preadolescence prevents reduced locomotor response to amphetamine in adult female but not male rats prenatally exposed to lipopolysaccharide.青春期前α5 GABA受体的正向调节可预防成年雌性而非成年雄性大鼠在产前暴露于脂多糖后对苯丙胺的运动反应降低。
Int J Dev Neurosci. 2017 Oct;61:31-39. doi: 10.1016/j.ijdevneu.2017.06.001. Epub 2017 Jun 10.
3
Further evaluation of the potential anxiolytic activity of imidazo[1,5-a][1,4]diazepin agents selective for α2/3-containing GABA receptors.对选择性作用于含α2/3的GABA受体的咪唑并[1,5-a][1,4]二氮䓬类药物潜在抗焦虑活性的进一步评估。
Pharmacol Biochem Behav. 2017 Jun;157:35-40. doi: 10.1016/j.pbb.2017.04.009. Epub 2017 Apr 22.
4
Alleviation of Multiple Asthmatic Pathologic Features with Orally Available and Subtype Selective GABA Receptor Modulators.口服可用的亚型选择性GABA受体调节剂对多种哮喘病理特征的缓解作用
Mol Pharm. 2017 Jun 5;14(6):2088-2098. doi: 10.1021/acs.molpharmaceut.7b00183. Epub 2017 May 1.
5
Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABA receptor ligand MP-III-024.新型α2/3选择性GABA受体配体MP-III-024的药理学及抗痛觉过敏特性
Brain Res Bull. 2017 May;131:62-69. doi: 10.1016/j.brainresbull.2017.03.001. Epub 2017 Mar 4.
6
Synthesis and Characterization of a Novel γ-Aminobutyric Acid Type A (GABA) Receptor Ligand That Combines Outstanding Metabolic Stability, Pharmacokinetics, and Anxiolytic Efficacy.一种新型γ-氨基丁酸A型（GABA）受体配体的合成与表征，该配体兼具出色的代谢稳定性、药代动力学和抗焦虑功效。
J Med Chem. 2016 Dec 8;59(23):10800-10806. doi: 10.1021/acs.jmedchem.6b01332. Epub 2016 Nov 28.
7
Sex-Dependent Anti-Stress Effect of an α5 Subunit Containing GABA Receptor Positive Allosteric Modulator.含α5亚基的GABA受体正变构调节剂的性别依赖性抗应激作用。
Front Pharmacol. 2016 Nov 22;7:446. doi: 10.3389/fphar.2016.00446. eCollection 2016.
8
A Review of the Updated Pharmacophore for the Alpha 5 GABA(A) Benzodiazepine Receptor Model.α5γ-氨基丁酸A（GABA(A)）苯二氮䓬受体模型更新药效团综述。
Int J Med Chem. 2015;2015:430248. doi: 10.1155/2015/430248. Epub 2015 Nov 10.
9
Selective targeting of the α5-subunit of GABAA receptors relaxes airway smooth muscle and inhibits cellular calcium handling.选择性靶向γ-氨基丁酸A（GABAA）受体的α5亚基可舒张气道平滑肌并抑制细胞内钙处理。
Am J Physiol Lung Cell Mol Physiol. 2015 May 1;308(9):L931-42. doi: 10.1152/ajplung.00107.2014. Epub 2015 Feb 6.
10
Behavioral effects of the benzodiazepine-positive allosteric modulator SH-053-2'F-S-CH₃ in an immune-mediated neurodevelopmental disruption model.苯二氮䓬类正变构调节剂SH-053-2'F-S-CH₃在免疫介导的神经发育破坏模型中的行为效应
Int J Neuropsychopharmacol. 2015 Jan 30;18(4):pyu055. doi: 10.1093/ijnp/pyu055.
Zotero 插件